Ketamine Recruiting Phase 2 Trials for Tinnitus Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03336398Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus